Takehito Igarashi
Overview
Explore the profile of Takehito Igarashi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
351
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Okazaki-Hada M, Fukuda I, Nagaoka R, Nagao M, Igarashi T, Kobayashi S, et al.
Ther Adv Endocrinol Metab
. 2022 Dec;
13:20420188221139652.
PMID: 36533183
Pheochromocytomas can present with various symptoms. Nonspecific manifestations of pheochromocytoma include intestinal pseudo-obstruction and weight loss. Here, we present a case of pheochromocytoma in which prolonged intestinal pseudo-obstruction due to...
2.
Nagaoka R, Saitou M, Nagahama K, Okamura R, Akasu H, Igarashi T, et al.
J Nippon Med Sch
. 2022 Oct;
90(5):408-413.
PMID: 36273906
Downhill varices are usually caused by superior vena cava (SVC) obstruction due to bronchogenic carcinoma or mediastinal tumors. These structures exhibit retrograde blood flow and are located in the proximal...
3.
Matano F, Murai Y, Watanabe A, Shirokane K, Igarashi T, Shimizu K, et al.
Front Endocrinol (Lausanne)
. 2021 Dec;
12:703410.
PMID: 34858321
To the best of our knowledge, we report a case of MEN2A complicated by moyamoya syndrome. A 52-year-old woman presented with vertigo. Magnetic resonance angiography (MRA) revealed bilateral supraclinoid stenosis...
4.
Kuribayashi-Hamada Y, Ishibashi M, Tatsuguchi A, Asayama T, Takada-Okuyama N, Onodera-Kondo A, et al.
J Nippon Med Sch
. 2021 Nov;
89(3):301-308.
PMID: 34840214
Background: Primary thyroid lymphoma (PTL) is a rare disease frequently arising against a background of autoimmune thyroiditis. It has recently been reported that the inactivation of the NF-κB negative regulator...
5.
Nagaoka R, Sugitani I, Kazusaka H, Matsui M, Sen M, Saitou M, et al.
J Nippon Med Sch
. 2021 Sep;
89(3):277-286.
PMID: 34526468
Background: Endoscopic thyroidectomy offers excellent cosmetic outcomes but requires some time for surgeons to become proficient. We examined the learning curve for the first 100 patients treated by a single...
6.
Shimizu K, Shimizu K, Okamura R, Igarashi T, Nagaoka R, Sanada M, et al.
Surg Today
. 2019 Nov;
50(10):1126-1137.
PMID: 31728730
Purpose: To describe and evaluate our video-assisted neck surgery (VANS) method for thyroid and parathyroid diseases. Methods: We describe in detail the VANS method for enucleation, lobectomy, total (nearly total)...
7.
Nagaoka R, Sugitani I, Sanada M, Jikuzono T, Okamura R, Igarashi T, et al.
J Nippon Med Sch
. 2018 Aug;
85(3):178-182.
PMID: 30135345
Background: Multiple endocrine neoplasia type 2B (MEN2B) is an extremely rare syndrome mainly caused by RET918 germline mutations. MEN2B typically causes medullary thyroid carcinoma (MTC), pheochromocytoma, and unique physical characteristics...
8.
Ohashi R, Kawahara K, Namimatsu S, Okamura R, Igarashi T, Sugitani I, et al.
Hum Pathol
. 2017 Apr;
67:11-17.
PMID: 28411177
Solid variant of papillary thyroid carcinoma (PTC) is characterized by a solid component (SC) retaining classical cytological features of PTC. Despite some controversies, PTC with SC (PTCSC) cases have poor...
9.
Ohashi R, Murase Y, Matsubara M, Watarai Y, Igarashi T, Sugitani I, et al.
Diagn Cytopathol
. 2017 Feb;
45(5):391-398.
PMID: 28224716
Background: Solid variant of papillary thyroid carcinoma is a rare subtype of papillary thyroid carcinoma (PTC) containing a solid component (SC), and thus its cytological and clinicopathological features remain elusive....
10.
Ohashi R, Kawahara K, Namimatsu S, Igarashi T, Sakatani T, Sugitani I, et al.
Histopathology
. 2016 Nov;
70(5):775-781.
PMID: 27882585
Aims: Solid variant of papillary thyroid carcinoma (SVPTC) is characterized by a solid component (SC) involving more than 50% of the tumour with the preservation of the classical cytological features...